225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study

Sathekge, Mike; Bruchertseifer, Frank; Knoesen, Otto; Reyneke, Florette; O. Lawal, Ismaheel; Lengana, Thabo; Davis, Cindy; Mahapane, Johncy; Corbett, Ceceila; Vorster, Mariza; Morgenstern, Aliyah

doi:10.1007/s00259-018-4167-0

Public

225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study

Published in European Journal of Nuclear Medicine and Molecular Imaging • Sep 19, 2018

Authors:

Mike Sathekge

Frank Bruchertseifer

Otto Knoesen

Abstract

Abstract Background A remarkable therapeutic efficacy has been demonstrated with 225 Ac-prostate-specific membrane antigen (PSMA)-617 in heavily pre-treated metastatic castration-resistant prostate cancer (mCRPC) patients. We report our experience with 225 Ac-PSMA-617 therapy in chemotherapy-naïve p...

Subject

Medicine

Prostate cancer

Chemotherapy

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!